IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 37 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q3 2013. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $0 | – | 2,775 | +155.8% | 0.00% | – |
Q2 2016 | $0 | – | 1,085 | -13.2% | 0.00% | – |
Q1 2016 | $0 | – | 1,250 | +733.3% | 0.00% | – |
Q3 2015 | $0 | -100.0% | 150 | -96.2% | 0.00% | – |
Q3 2014 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
Q2 2014 | $4,000 | – | 4,000 | +708.1% | 0.00% | – |
Q4 2013 | $0 | -100.0% | 495 | -83.5% | 0.00% | – |
Q3 2013 | $8,000 | -95.5% | 3,000 | -96.8% | 0.00% | – |
Q2 2013 | $179,000 | – | 92,386 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|